Highlights in IBD Epidemiology and Its Natural History in the Paediatric Age.
about
Inflammatory bowel disease imaging: Current practice and future directionsSelf-management in patients with inflammatory bowel disease: strategies, outcomes, and integration into clinical careImplications of the colonic deposition of free hemoglobin-α chain: a previously unknown tissue by-product in inflammatory bowel diseaseDetection of a fluorescent-labeled avidin-nucleic acid nanoassembly by confocal laser endomicroscopy in the microvasculature of chronically inflamed intestinal mucosa.Prospective evaluation of free-breathing diffusion-weighted imaging for the detection of inflammatory bowel disease with MR enterography in childhood population.Toward a better understanding of the central consequences of intestinal inflammation.Vedolizumab Therapy in Severe Pediatric Inflammatory Bowel Disease.Pilot Study of Functional Magnetic Resonance Imaging Responses to Somatic Pain Stimuli in Youth With Functional and Inflammatory Gastrointestinal Disease.PedsQL gastrointestinal symptoms scales and gastrointestinal worry scales in pediatric patients with inflammatory bowel disease in comparison with healthy controls.Anti-TNFα therapy for inflammatory bowel diseases is associated with Epstein-Barr virus lytic activation.Methionine restriction on oxidative stress and immune response in dss-induced colitis mice.Melatonin alters amino acid metabolism and inflammatory responses in colitis mice.Pyrrolidine Dithiocarbamate Inhibits NF-KappaB Activation and Upregulates the Expression of Gpx1, Gpx4, Occludin, and ZO-1 in DSS-Induced Colitis.A systems pharmacology model for inflammatory bowel disease.Pediatric Crohn's Disease in Bahrain
P2860
Q26774602-4DCAABEA-CE64-4393-B8B8-7DC8759F468EQ28070335-6E150114-9074-4E44-9661-167934794DDCQ34052630-E44C56DA-8F22-4722-8284-562236A25A57Q34960433-5D87DFA6-FFE3-4293-8B2B-8957A3D8CBEDQ36839247-7EAA2211-29E4-411D-B391-A3903A6D3489Q38588312-B85B20B6-3158-4A8F-98EC-1D13C16FC4BFQ39419343-078BCF07-213D-4E81-886E-A83F919EBC21Q39441089-FE33403F-A999-4C1B-A5CA-22624533873AQ40265182-C143541F-C0A5-43CE-BC7B-99041E6A4A06Q41033177-EBFD2D5C-A975-4BAA-BDA8-71E0127D0926Q41280134-14572BB3-9272-4C2C-A969-7C68D6BC5889Q47656287-9BC303F9-DA5D-43E4-B87D-7AA429008773Q51333250-E7DC0BC1-9439-488B-AC78-6CD653A9CE8AQ52364429-63BA0494-1012-4AC6-9640-70577B1CFC84Q57100278-E2C75EB2-DFC1-4184-A5EA-366AB39694C3
P2860
Highlights in IBD Epidemiology and Its Natural History in the Paediatric Age.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Highlights in IBD Epidemiology and Its Natural History in the Paediatric Age.
@en
Highlights in IBD Epidemiology and Its Natural History in the Paediatric Age.
@nl
type
label
Highlights in IBD Epidemiology and Its Natural History in the Paediatric Age.
@en
Highlights in IBD Epidemiology and Its Natural History in the Paediatric Age.
@nl
prefLabel
Highlights in IBD Epidemiology and Its Natural History in the Paediatric Age.
@en
Highlights in IBD Epidemiology and Its Natural History in the Paediatric Age.
@nl
P2860
P356
P1476
Highlights in IBD Epidemiology and Its Natural History in the Paediatric Age.
@en
P2093
Graziella Guariso
Marco Gasparetto
P2860
P304
P356
10.1155/2013/829040
P577
2013-12-24T00:00:00Z